Kawasaki Mami, Nakano Kazuya, Ohnishi Takashi, Sekine Masashi, Watanabe Eizo, Oda Shigeto, Nakada Taka-Aki, Haneishi Hideaki
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:1844-1847. doi: 10.1109/EMBC44109.2020.9175225.
Sepsis is life threatening organ dysfunction caused by microcirculatory dysfunction. With progression of sepsis, the patients are likely to develop septic shock which is associated with multi organ dysfunction. To treat sepsis and septic shock, Thrombomodulin alfa (TM alfa) was developed. Direct observation of the microcirculation may provide new and rich information in terms of the effect of TM alfa on sepsis. Thus we conducted rodent experiments in which we observed the microcirculation with a non-contact optical imaging setup and measured lactate value from collected blood. From the acquired motion pictures, we estimated the blood velocity. As a result, from experiments, the sham rats showed no significant change in both lactate value and the blood velocity during the observation. On the other hand, lactate value of the septic model rats increased and the blood velocity of them decreased. Lactate value of the septic model rats treated with TM alfa decreased after showing an increase while the blood velocity of them increased after showing a decrease. These findings suggest that microcirculatory alteration may be a sign of sepsis as well as septic shock progression and that the TM alfa may be effective for the treatment of sepsis and septic shock.
脓毒症是由微循环功能障碍引起的危及生命的器官功能障碍。随着脓毒症的进展,患者可能会发展为脓毒性休克,这与多器官功能障碍有关。为了治疗脓毒症和脓毒性休克,研发了重组人血栓调节蛋白(TMα)。直接观察微循环可能会提供关于TMα对脓毒症疗效的丰富新信息。因此,我们进行了啮齿动物实验,在实验中我们使用非接触式光学成像装置观察微循环,并测量采集血液中的乳酸值。从获取的动态图像中,我们估算了血流速度。结果,在实验中,假手术大鼠在观察期间乳酸值和血流速度均无显著变化。另一方面,脓毒症模型大鼠的乳酸值升高,血流速度降低。用TMα治疗的脓毒症模型大鼠的乳酸值在升高后降低,而血流速度在降低后升高。这些发现表明,微循环改变可能是脓毒症以及脓毒性休克进展的一个迹象,并且TMα可能对脓毒症和脓毒性休克的治疗有效。